Małgorzata Wierzbicka
Renata Kopczyk5*
Aleksandra Gerlach
Joanna Rymaszewska- 1Research and Development Center, Regional Specialist Hospital, Wrocław, Poland
- 2Institute of Human Genetics, Polish Academy of Sciences, Poznań, Poland
- 3Faculty of Medicine, Wroclaw University of Science and Technology, Wrocław, Poland
- 4Head of Department of Clinical Neurosciences, Faculty of Medicine, Wroclaw University of Science and Technology, Wrocław, Poland
- 5Faculty of Management, Wroclaw University of Science and Technology, Wrocław, Poland
A Correction on
Therapeutic and legal aspects of psilocybin in cancer-related depression
By Wierzbicka M, Kopczyk R, Gerlach A and Rymaszewska J (2025) Front. Psychiatry 16:1591864. doi: 10.3389/fpsyt.2025.1591864
In the original article, the author “Małgorzata Wierzbicka” was erroneously listed as “Wierzbicka Małgorzata.” Her name has been updated in the author list and correspondence section.
The article citation now reads:
“Wierzbicka M, Kopczyk R, Gerlach A and Rymaszewska J (2025) Therapeutic and legal aspects of psilocybin in cancer-related depression. Front. Psychiatry 16:1591864. doi: 10.3389/fpsyt.2025.1591864”
The copyright statement reads:
“© 2025 Wierzbicka, Kopczyk, Gerlach and Rymaszewska. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.”
In the Author Contributions statement, the initials “WM” have been changed to “MW”.
The original version of this article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: head neck cancer, treatment, distress, depression, antidepressant utilization, psilocybin, legislation
Citation: Wierzbicka M, Kopczyk R, Gerlach A and Rymaszewska J (2025) Correction: Therapeutic and legal aspects of psilocybin in cancer-related depression. Front. Psychiatry 16:1698185. doi: 10.3389/fpsyt.2025.1698185
Received: 04 September 2025; Accepted: 04 September 2025;
Published: 11 September 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Wierzbicka, Kopczyk, Gerlach and Rymaszewska. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Małgorzata Wierzbicka, YWxnb3J6YXRhLndpZXJ6Ymlja2FAcHdyLmVkdS5wbA==; Renata Kopczyk, cmVuYXRhLmtvcGN6eWtAcHdyLmVkdS5wbA==